The effect of hydroxyurea in spinal muscular atrophy cells and patients
- 1 May 2008
- journal article
- clinical trial
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 268 (1-2) , 87-94
- https://doi.org/10.1016/j.jns.2007.11.012
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproateAnnals of Neurology, 2006
- Determinants of Exon 7 Splicing in the Spinal Muscular Atrophy Genes, SMN1 and SMN2American Journal of Human Genetics, 2006
- Essential Role for the SMN Complex in the Specificity of snRNP AssemblyScience, 2002
- SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2beta1Human Molecular Genetics, 2002
- Correlation between severity and SMN protein level in spinal muscular atrophyNature Genetics, 1997
- Identification of Proximal Spinal Muscular Atrophy Carriers and Patients by Analysis of SMNT and SMNC Gene Copy NumberAmerican Journal of Human Genetics, 1997
- Spinal Muscular AtrophyAmerican Journal of Physical Medicine & Rehabilitation, 1995
- Hydroxyurea therapy in β‐thalassaemia intermedia: improvement in haematological parameters due to enhanced β‐globin synthesisBritish Journal of Haematology, 1995
- Hematologic Responses of Patients with Sickle Cell Disease to Treatment with HydroxyureaNew England Journal of Medicine, 1990
- Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.Journal of Medical Genetics, 1978